Lacrifill: Revolutionizing Dry Eye Treatment

Treatment for Dry Eyes

Lacrifill is transforming the way dry eye disease is treated. Common among the aging population, post-surgical patients, and contact lens wearers, traditional treatments have often faced a variety of issues and complications. Lacrifill offers an innovative solution to these challenges. Call now to learn more at 251-351-3214.

Prevalence of Dry Eye:

  • Affects over 16 million people in the U.S.
  • Particularly common in peri-menopausal and postmenopausal women (79% prevalence).
  • 79% of contact lens wearers report dry eye symptoms.
  • Post-surgical impact: 28% after LASIK, 37.4% after cataract surgery.

Lacrifill’s Unique Solution:

  • Composition: Made of crosslinked hyaluronic acid, this canalicular gel provides long-lasting relief.
  • FDA Approved: Safe and effective with a unique formulation.
  • Procedure: Quick and simple, involving a five-minute office visit to place the gel into the lower tear duct using a lacrimal irrigator.
  • Mechanism: The gel fills the eye’s drainage system, retaining natural tears and maintaining lubrication.


  • Effective: Significant improvements in dry eye scores at one, three, and six months.
  • Safe and Well-Tolerated: Minimal adverse effects, with mild and temporary discomfort.
  • Long-Lasting: Relief lasts for six months, meeting ideal treatment criteria.
  • Reversible: Offers flexibility and ease of administration every six months.

Lacrifill provides a robust, comprehensive, and patient-friendly option for managing chronic dry eye, making it a significant advancement in dry eye treatment. Now available at the Eisner Laser Center.